12/11/2025
Reducing the burden of diabetes: Starting in January 2026, a nonprofit, Civica Rx, will launch an affordable long acting basal insulin.
Starting January 2026, Civica Rx will launch affordable long-acting insulin glargine, offering a low-cost option to help people with diabetes manage blood sugar.